Sign Up Today and Learn More About iECURE Stock
Invest in or calculate the value of your shares in iECURE or other pre-IPO companies through EquityZen's platform.
iECURE Stock (IEEC)
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
About iECURE Stock
Founded
2012
Headquarters
Philadelphia, PA, US
Industries
Science and Engineering, Health Care, Biotechnology
iECURE Press Mentions
Stay in the know about the latest news on iECURE
iECURE Announces FDA Clearance of Investigational New Drug Application for ECUR-506 to Initiate OTC-HOPE Trial ...
finance • Jul 03, 2024
iECURE Receives FDA Fast Track Designation for ECUR-506 for the Treatment of Neonatal Onset Ornithine ...
businesswire • Jun 05, 2024
University of Pennsylvania gene-editing spinout iEcure hits the FDA trifecta
bizjournals • May 20, 2024
iECURE Receives FDA Fast Track Designation for ECUR-506 for the Treatment of Neonatal Onset Ornithine ...
finance • May 20, 2024
Precision BioSciences Gets FDA Fast Track Designation for Program to Treat Genetic Urea Cycle Disorder in Newborns
marketwatch • May 20, 2024
iECURE Management
Leadership team at iECURE
Vice President, Therapeutic Area Lead, Urea Cycle Disorders
George Diaz
CBO
Alex Monteith
Join now and verify your accreditation status to gain access to:
- iECURE current valuation
- iECURE stock price
- Available deals in iECURE and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading iECURE Stock
How to invest in iECURE stock?
Accredited investors can buy pre-IPO stock in companies like iECURE through EquityZen funds. These investments are made available by existing iECURE shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell iECURE stock?
Shareholders can sell their iECURE stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
